CINSARC signature outperforms gold-standard TNM staging and consensus molecular subtypes for clinical outcome in stage II–III colorectal carcinoma

Anne-Cécile Brunac, Joanna Fourquet, Gaëlle Perot, Marion Jaffrelot, Julie Meilleroux, Marie Danjoux, Thomas Filleron, Vincent Nicolaï, Rosine Guimbaud, Samira Icher, Nadim Farés, Janick Selves, Frédéric Chibon
Modern Pathology · Springer Nature · 2022-10-06 · DOI: 10.1038/s41379-022-01166-9

Abstract

Modern Pathology, Published online: 06 October 2022; doi:10.1038/s41379-022-01166-9 CINSARC signature outperforms gold-standard TNM staging and consensus molecular subtypes for clinical outcome in stage II–III colorectal carcinoma

Read at publisher →

Similar articles